Professor, Department of Otolaryngology, Neurosurgery, and Ophthalmology
Boston Med Ctr
Boston, Massachusetts, United States
Anand K. Devaiah, MD, FACS, is a Professor in the Departments of Otolaryngology, Neurological Surgery, and Ophthalmology at Boston University. His clinical practice is in anterior and lateral skull base surgery, including endoscopic/minimally invasive surgical techniques, open skull base surgery, head and neck cancer, and complex otology. His work bridges the worlds of development and implementation, leading and facilitating collaborations focused on improving value in the health care system through technological innovations. This includes development, evaluation, implementation, research, administration, and regulatory pathways. He works closely with companies -- from startups to established enterprises – in different ways including team-based product development, building core business strategies, marketing strategies, corporate governance, developing expanded use cases for existing technology, and as an investor. This includes health care and non-health care technologies. He has also served as a Medical Officer/Fellow with the Food and Drug Administration in the Center for Devices and Radiologic Health as a part of the Ear, Nose, and Throat Branch from 2015-2017. He was then named the inaugural Director of the Biomedical & Health Technology Development & Transfer Domain in the Boston University Institute for Health System Innovation & Policy (IHSIP), and remained in this position until conclusion of the IHSIP Charter at the end of 2021. During his tenure, Dr. Devaiah led the Institute’s cross-disciplinary work which included bringing new technology and expanded use cases from the bench to the bedside, intersecting with the wraparound systems integral to health care. The domain’s programs and research lines included device and drug innovations for diagnostics and therapeutic applications, digital health platforms, educational innovations, public health policy, and Social Determinants of Health and their impact. He continues to serve in similar capacities, through continuing work in the innovation space within and outside the University, and in service to different Societies and organizations.
A Novel Artificial Intelligence Model for Optimizing Treatment of Salivary Gland Malignancies
Saturday, September 28, 2024
1:06 PM – 1:12 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
A Novel Artificial Intelligence Model for Optimizing Treatment of Salivary Gland Malignancies
Sunday, September 29, 2024
1:00 PM – 1:06 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Digital Health 2024: How Disruptive Technologies are Redefining Otolaryngology Practice
Monday, September 30, 2024
2:30 PM – 3:30 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Design, Build, and Use It! A Crash Course and Guide to Device Innovation, 2024
Tuesday, October 1, 2024
8:00 AM – 9:00 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
What Is Evidence: Medicine in the Age of ChatGPT and Dr. Google
Tuesday, October 1, 2024
9:30 AM – 10:30 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Current Diagnosis and Management: Malignant Sinonasal and Anterior Skullbase Neoplasms
Tuesday, October 1, 2024
11:00 AM – 12:00 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.